Get Live Data
Less Ads, More Data, More Tools Register for FREE
REMOVE ADS
REMOVE ADS

Latest Share Chat

  2. Share Prices
  3. GWP.L Share Price
  4. GWP.L Share Regulatory News
  5. Block Listing Application

Pin to quick picksGWP.L Regulatory News (GWP)

GWP.L Information
  • There is currently no data for GWP

Block Listing Application

18 Mar 2016 15:34

RNS Number : 6335S
GW Pharmaceuticals PLC
18 March 2016
 

 

GW Pharmaceuticals PLC ("GW Pharmaceuticals")

 

BLOCK LISTING APPLICATION

 

Cambridge, UK, 18 March 2016: GW Pharmaceuticals (AIM: GWP, Nasdaq: GWPH) hereby provides notification that application has today been made to the London Stock Exchange for admission to trading on AIM of a block of 1,000,000 new ordinary shares of 0.1p each.

These new ordinary shares will be issued from time to time pursuant to the exercise of employee share options under the GW Pharmaceuticals Long Term Incentive Plan 2008.

On exercise the shares will be issued credited as fully paid and will rank pari passu with the existing ordinary shares in issue.

It is expected that such admission will become effective on 24 March 2016.

 

 

For further information, please contact:

 

GW Pharmaceuticals PLC +44 (0)1980 557 000

Adam George, Company Secretary

 

Peel Hunt LLP (Nominated Adviser)

James Steel/Oliver Jackson +44 (0) 20 7418 8900

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
LISSFEFIAFMSEDD
12345678910
Date   Source Headline
18th Feb 201410:20 amRNSBlocklisting Interim Review
12th Feb 20141:47 pmRNSAdditional Listing
10th Feb 20145:00 pmRNSPresenting at Leerink Global Healthcare Conference
5th Feb 20147:00 amRNSQ1 2014 Financial Results and Operational Progress
31st Jan 20143:17 pmRNSHolding(s) in Company
29th Jan 20147:00 amRNSNotice of Results
17th Jan 20145:11 pmRNSHolding(s) in Company
16th Jan 201411:13 amRNSAdditional Listing
15th Jan 20144:34 pmRNSHolding(s) in Company
15th Jan 20144:33 pmRNSHolding(s) in Company
14th Jan 20144:23 pmRNSClosing of U.S. Follow-on Offering of Nasdaq ADSs
14th Jan 20147:00 amRNSAgreement with Ipsen for Sativex in Latin America
13th Jan 20145:00 pmRNSHolding(s) in Company
13th Jan 20145:00 pmRNSHolding(s) in Company
9th Jan 20147:00 amRNSRaises $87.9m on NASDAQ in U.S. Follow-On Offering
6th Jan 201412:18 pmRNSResults of General Meeting
6th Jan 201412:13 pmRNSFiles Amendment to Registration Statement
20th Dec 20132:05 pmRNSNotice of General Meeting and Follow-On Offering
11th Dec 20137:00 amRNSU.S. Patent Allowance for Cannabinoids in Glioma
6th Dec 20135:52 pmRNSPublication of UK Annual Report and Accounts
2nd Dec 20137:00 amRNSPresenting at Piper Jaffray Health Care Conference
29th Nov 20132:00 pmRNSBlocklisting Application
27th Nov 20137:00 amRNSSativex Regulatory Approval in Switzerland
26th Nov 20135:51 pmRNSDirector/PDMR Shareholding
26th Nov 20137:00 amRNSFiling of U.S. Annual Report on Form 20-F
19th Nov 20137:00 amRNSFinal Results
18th Nov 20136:00 pmRNSGW Presenting at Jefferies Healthcare Conference
15th Nov 20137:00 amRNSUpdate on Epidiolex in Childhood Epilepsy
12th Nov 20137:01 amRNSNotice of Results
11th Nov 20137:00 amRNSPhase 1b/2a trial for Glioblastoma Multiforme
21st Oct 20137:00 amRNSSuccessful Closing of Mutual Recognition Procedure
2nd Oct 20138:00 amRNSNew Sativex Data at ECTRIMS
24th Sep 20132:01 pmRNSGrant of Options
23rd Sep 201311:41 amRNSAgreement on Sativex Pricing in Germany
20th Sep 20137:00 amRNSPresenting at Aegis Capital Healthcare Conference
18th Sep 20137:00 amRNSGW Commences Trial of GWP42006 for Epilepsy
19th Aug 20137:00 amRNSBlocklisting Interim Review
14th Aug 20137:00 amRNSInvestigational New Drug Application for Sativex
8th Aug 20137:00 amRNSPresenting at the Canaccord Genuity Conference
5th Aug 20137:00 amRNS2013 Third Quarter Financial Results
5th Aug 20137:00 amRNSSativex MS Spasticity Cognition Study Results
22nd Jul 20137:00 amRNSFiles new application to expand Sativex to France
15th Jul 20137:00 amRNSNotice of Results
8th Jul 20137:00 amRNSProduct Launch
4th Jul 20138:31 amRNSHolding(s) in Company
10th Jun 201312:53 pmRNSDirector/PDMR Shareholding
3rd Jun 20137:00 amRNSSecond Quarter Financial Results
30th May 20135:30 pmRNSExercise of Over-Allotment Option
14th May 20131:00 pmRNSNotice of Results
10th May 20134:28 pmRNSHolding(s) in Company
12345678910

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Recently viewed
WPC
WPC.L
LSE
0.00%
INSE
Inspired
LSE
0.00%
TNON.US
Tenon Medical Inc
CBOE
45.71%
LGT
Lighthouse
LSE
0.00%
60LW
Elland 63
LSE
0.00%
Trending
TLW
Tullow Oil
LSE
4.79%
FORG
Forgent
LSE
0.00%
PAF
Pan African Resources
LSE
-5.92%
BRES
Blencowe Resources
LSE
-5.29%
TBN.US
Tamboran Resources Corp.
CBOE
-2.51%